Cantor Fitzgerald analysts paint a grim picture for equity markets (SP500), (COMP:IND), (DJI), pointing to significantly ...

Fintel reports that on April 22, 2025, Cantor Fitzgerald initiated coverage of Eli Lilly and (NYSE:LLY) with a Overweight ...

Cantor Fitzgerald initiated or transferred coverage on 10 large-cap U.S. biopharma stocks in a note Tuesday, highlighting a selective approach that favors dominant franchises with strong growth ...

As previously reported, Cantor Fitzgerald assumed coverage of Vertex Pharmaceuticals (VRTX) with an Overweight rating and a price target of ...

As previously reported, Cantor Fitzgerald analyst Carter Gould upgraded Regeneron (REGN) to Overweight from Neutral with a price target of ...

Cantor Fitzgerald analysts renewed their criticism of U.S. Health Secretary Robert F. Kennedy Jr. on Thursday, saying the layoffs at the Food and Drug Administration pose a risk to public safety and ...

Cantor Fitzgerald analysts initiated coverage of crypto exchange Coinbase (COIN) with an "Overweight" rating and price target ...

Verve Therapeutics (VERV) stock surged as promising trial data for cholesterol therapy VERVE-102 prompted Cantor Fitzgerald ...

Cantor Fitzgerald views Bob Duggan’s, Summit Therapeutics (SMMT) co-CEO and Chairman, stock option exercise “quite unusual” ...

One big question heading into Tesla's earnings call on Tuesday afternoon is whether the company will stick with its prediction for a return to growth in its automotive business this year. When ...

Cantor Fitzgerald Large Cap Focused Fund earns an Above Average Process Pillar rating. The main contributor to the rating is the parent firm's five-year risk-adjusted success ratio of 81%.

Cantor Fitzgerald International Eq Fund earns an Above Average Process Pillar rating. The leading factor in the rating is the parent firm's five-year risk-adjusted success ratio of 81%.